Curriculum Vitae Date of birth Nationality Qualifications
New York State Licensed Physician 1980MD Liverpool
Student clinical 1969 Surgical externship, Harrisburg PA1970 Psychiatry in Stockholm, Sweden
Appointments September 1971 - August 1972 House physician and house surgeon Whiston Hospital, Prescott September 1972 - September 1973 SHO in psychiatry Hackney and St Bartholomew's Hospital October 1973 - September 1974 Research registrar St Bartholomew's Hospital Conducting drug trials and developing models for the assessment of psychopharmacological agents in vivo October 1974 - April 1975 SHO in general medicine St Leonard's Hospital May 1975 - September 1975 Locum assistant psychiatrist Central Lassarettet, Boden, Sweden October 1975 - March 1977 SHO/registrar Bethlem Royal and Maudsley Hospitals Psychiatric rotation at the joint hospitals April 1977 - September 1979 Research assistant and lecturer Institute of Psychiatry Honorary senior registrar Maudsley Hospital, London under Professor Malcolm Lader in the department of pharmacology. Work related to a series of studies mainly on benzodiazepines and their long-term effects November 1979 - June 1981 Psychiatrist II Rockland Psychiatric Centre Research psychiatrist Rockland Research Institute, Orangeburg, New York, with Dr Nathan Kline Clinical duties and clinical research October 1980 - 1981 Clinical assistant professor Department of Psychiatry, New York University Medical Centre July 1981 - May 1982 Senior registrar Bethlem Royal and the Maudsley Hospitals Working in the Emergency Clinic June 1982 - 1995 Consultant psychiatrist Charing Cross Hospital (Riverside Mental Health) Adult General Psychiatry Senior lecturer Charing Cross & Westminster Medical School University of London 1995 - 2003 Consultant psychiatrist/ Medical Director (Jan 1998-2003) Charter Clinic Chelsea 7 Radnor Walk London SW3 4BP 2003 – 2005 Independent Practice Consultant Psychiatrist 15 Basil Mansions Basil Street London SW3 1AP 2005 – 2006 Independent Practice Consultant Psychiatrist Keats House 24-26 St. Thomas Street London SE1 9RS 2007 – present Independent Practice Consultant Psychiatrist 11 Sloane Court West London SW3 4TD 1998 Consultant to Feighner Research Institute 1999 - 2000 Director of Research for Feighner Research Institute UK Additional 1976 Locum consultant psychiatrist experience Guernsey, Channel Islands 1977 - 1979 Regular general practice sessions Membership of
Ex-Council Member of the British Association
Societies
Member of CINPWorshipful Society of Apothecaries of London
Lecturing
On average one lecture per week in the past, mainly to postgraduate audiences and mainly on the treatment of mood disorders. Organiser of several scientific symposia
The Royal College
Public Education Committee, dealing with the
of Psychiatrists
media on behalf of The Royal College. Thisinvolves about three contacts per weekand frequent media appearances
Medicolegal experience
Mental Health ActWide experience in the assessment of criminal and civil matters, preparationof expert reports, most recently in childcare proceedings
Charitable work Broadway Housing Providing supported accommodation for mentally ill patients
Founding Member of The Homeless Fund an initiative on homelessness
Advisor to The Hamlet Trust, a self-help initiative providing resources to the old 'iron curtain' countries Additionally
Recommended in the Good Housekeeping Magazine Guide as one of Britain's top specialists in 1992
Reviewer of scientific papers for numerous psychiatric journals
Languages
Fluent in German and SwedishSome knowledge of French
Publications Original papers A clinical pharmacological study of the effect of clomipramine and protriptyline on the uptake of tritiated 5HT and DA in platelets from depressed patients Hallström C, Pare M, Rees W, Trenchard A & Turner P Journal de Pharmacologie, Supp No. 2 1975 Platelet uptake of 5HT and dopamine in depression Hallström C, Pare M, Linford-Rees M, Trenchard A & Turner P Postgraduate Medical Journal 1976 52, 40-44 Antidepressant blood levels in acute overdose Hallström C & Gifford L Postgraduate Medical Journal 1976 52, 687-688 ECG changes on butriptyline Hallström C & Brooks N Communication in Psychopharmacology 1979 3, 55-59 Diazepam and its metabolite nordiazepam, in saliva, plasma and CSF Hallström C, Lader M & Curry S British Journal of Clinical Pharmacology 1980 9, 333-339 A stable isotope dilution assay for the antiparkinsonian drug benzotropine in biological fluids Jindal S, Lutz T, Hallström C & Vestergaard P Clinical Chimica Acta 1981 112, 267-273 The effects of propranolol and diazepam alone and in combination, on the effects of chronic anxiety Hallström C, Treasaden I, Edwards G & Lader M British Journal of Psychiatry 1981 139, 417-421 Protection of patients on MAOIs against hypertensive crises Kline N, Cooper T, Suckow R, Hallström C & Brebbia R Journal of Clinical Psychopharmacology 1981 1, 410-411 Benzodiazepine withdrawal phenomena Hallström C & Lader M International Pharmacopsychiatry 1981 16, 235-244 The effects of ginseng on physiological, biochemical and psychological measure, after sleep deprivation Hallström C, Fulder S & Carruthers M American Journal of Chinese Medicine 1982 6, 277-282 The incidence of benzodiazepine dependence Hallström C & Lader M Journal of Psychiatric Treatment and Evaluation June 1982 4,293-296 Will amitriptyline prevent the "cheese" reaction of monoamine oxidase inhibitors? Pare M, Kline N, Hallström C & Cooper T Lancet 1982, 183-186 Steady state plasma levels of lofepramine and desipramine monitored during a clinical double-blind comparison: a preliminary report Hallström C Chapter in ‘Lofepramine in the treatment of depressive disorders’ 1988 Angst J and Wogan B (eds) Vieweg, Braunschweig Benzodiazepine dependent patients and their psychological treatment Crouch G, Robson M & Hallström C Progress in Neuropsychopharmacology & Biological Psychiatry 1988 12, 503- 510 Rapid response to buspirone: assessment in a general practice setting Hallström C & Cox J British Journal of Clinical Practice 2: 65-80 (1991) Self-help and benzodiazepine withdrawal Tattersall ML and Hallström C Journal of Affective Disorders 24 (1992) 193-198 Inadequate treatment response to des-enkephalin-gamma-endorphin compared with thioridazine and placebo in schizophrenia Montgomery SA, Hallström C et al Acta Psychiatrica Scandinavica (86) 1992, 97-103 An open study of remoxipride in the long-term treatment of schizophrenia T Ashwood, C Hallström et al Journal of Psychopharmacology 6(4) 1992 519-525 The role of coping strategies in protecting individuals against long-term tranquilliser use Bish A, Golombok S, Hallström C, Fawcett S (submitted for publication) A controlled trial of dothiepin and placebo in treating benzodiazepine withdrawal symptoms Tyrer P, Ferguson B, Hallstrm C, Mitchie M, Tyrer S, Cooper S, Caplan R,
Barczak PBritish Journal of Psychiatry (1996) vol 168, page 457-461
Pharmacist’ Mental Health Role Questioned
Hallström CProgress in Neurology and Psychiatry Vol.2 Issue 2 March/April 1998
Books/Chapters/Reviews Family Health Encyclopaedia, Editor Good Housekeeping 1983 Benzodiazepines: clinical practice and central mechanisms (in) Recent Advances in Clinical Psychiatry (5) 1985 Granville-Grossman K (ed), Livingstone Efficacy and problems of MAO inhibitor antidepressants Cody D & Hallström C Chapter in Antidepressants for elderly people, 1989 Ghose K (ed), Chapman & Hall
Hallström C: Coping with anxiety; the patient's predicament (in) The anxiolytic Jungle; Where next? Edited by Wheatley D John Wiley & Sons, Chichester, 1990
Certificate of educational merit in the British Medical Association's Film and Video Competition, for a video called Stress and distress, 1990 Monographs on chlordiazepoxide, lorazepam and meprobamate (in) Therapeutic Drugs, a clinical pharmacopoeia, 1991 Mind and body Hallström C (in) A History of Medicine Edited by N Duin and J Sutcliffe Publishers Simon & Schuster, 1992 Benzodiazepine dependence - Editor Hallström C Oxford University Press, 1993
Humphreys & Hallström (1995) Chapter 10: Benzodiazepine discontinuation phenomena in Nutt & Mendelson (ed) ‘Hypnotics and Anxiolytics’ Balliere's Clinical Psychiatry, vol 1, no 3 Balliere Tindall, London, August 1995 The psychopharmacology of mood disorders in primary care Proceedings of the autumn meeting of The British Association of Psychopharmacology Supplement in Primary Care Psychology (Editor) Hallström C Anxiety & depression: your questions answered Hallström & McClure Publishers Churchill Livingstone, August 1998 Benzodiazepine dependence and withdrawal - an update Humphreys S & Hallström C (1995) 99-107 Vol 1 No 2 Primary Care Psychiatry Dangers of Community Psychiatry C.Hallström Badania Nad Schizofrenia, 1998, I,1 Mania: Hallström in Clinical General Practice Vol. 1 Ed: Mary Selby – Butterworth, 2004 Depression Your Questions Answered Hallström & McClure Elsever, 2005 (translated into Polish in 2006) Chapter On Anxiety in: The Mind: A User’s Guide Ed: Raj Persaud, Transworld Publishers (2007) Abstracts/Articles/Letters The future of psychiatry Eds Creed F & Hallström C Geigy Publications, 1979 Prediction of response to anti-anxiety agents Hallström C & Lader M Proceedings of the 11th CINP, Pergammon Press, 1979 Benzodiazepine withdrawal phenomena Hallström C & Lader M Abstracts of the 12th CINP Congress 1980, Progress in Neuropsychopharmacology (sup), 186 The use and abuse of tranquillisers Hallström C Update July 1982 4, 43-50 Which hypnotic - if any? Hallström C British Journal of Hospital Medicine 1983 30, 188-192 The current view on minor tranquillisers and new developments Hallström C Postgraduate Doctor 1984 7, 366-372 Practical aspects of the use of beta-blockers in anxiety states: morbid anxiety Hallström C Postgraduate Medical Journal 1984 60 (supp 2), 26-30 Thyroid abnormalities and violent suicide Drummond L, Lodrick M & Hallström C British Journal of Psychiatry 1984 144, 213 (Letter) Specific benzodiazepine receptors: What is the latest thinking? Hallström C Medical Dialogue 1985 58, 2-4 Patients' attitudes to depot neuroleptics Hallström C, Halstead S, Hays H Schizophrenia Research 1988 May, 209-210 Anxiolytic drugs; past, present and future Hallström C Holistic Medicine 1989 4, 157-163 Uses and abuses of benzodiazepines
Hallström CBritish Journal of Hospital Medicine 1989 41, 115
Benzodiazepines and medical negligence - the issues Hallström Abstracts of Autumn Quarterly Meeting of The Royal College of Psychiatrists, 1989 Uses and misuses of benzodiazepines Hallström C, Hawley C Postgraduate Doctor 13: 316-320 (1990) Medical aspects of benzodiazepine abuse Hallström C Practical reviews in Psychiatry, 2: 9, 3-5 (1990) Benzodiazepine and medical negligence Hallström C Update 40: 1139-1140 (1990) GBR 12909: a dose response relationship of the selective dopamine uptake inhibitor in major depression Fensbo C, Montgomery S, Andersen J, Hallström C, Schonbeck G, de Zwann M, Moller Neilsen E, Olafsen K, Ingwersen S: 17th Congress of the Collegium Internationale Neuro-Psychopharmacologicum 1990 (Tokyo) Buspirone in British general practice Hallström C 17th Congress of the Collegium Internationale Neuro-Psychopharmacologicum 1990 (Tokyo) Desenkephalin gamma endorphin and thioridazine in the treatment of schizophrenia; a placebo controlled study Montgomery S, Green M, Rimon R, Heikkila L, Foresstrom R, Hirsch S, Hallström C, Hippius H, Naber R, Kahn M, Stitsen J: 17th Congress of the Collegium Internationale Neuro-Psychopharmacologicum 1990 (Tokyo) Benzodiazepine dependent patients in different clinical settings
Hawley C, Crouch G, Tattersall M, Hallström C:British Association for PsychopharmacologySummer Meeting 1990 (Cambridge)
Tranquilliser addiction; medicolegal aspects Hallström C The Royal College of Psychiatrists Annual General Meeting 1990 (Birmingham) Benzodiazepine dependence; an incomplete picture The Royal College of Psychiatrists Annual Meeting 1990 (Birmingham) Current views on treating patients with anxiety: factors that affect the choice of drug Hallström C Prescriber Issue 28 34-38 (1991) The comparison of anxiety rating scales in a training situation Proceedings of the British Association of Psychopharmacology's Summer Meeting 1991 Bradford L, Hallström C, Gerristen van der Hoop, Stevens G Benzodiazepine dependence; who is responsible? Hallström C (Editorial) The Journal of Forensic Medicine 2: 5-7 (1991) Appropriate prescribing of the benzodiazepines Hallström Pulse 51: Page 58 (1991) Anxiety disorders and their management Hallström C Prescriber Vol 3, Issue 19 31-38 (1992) Buspirone - different mode of action reduces anxiety treatment complications Hallström C Pulse Vol 50: No 21 75 Watch out for depression in sleep disorder cases
Hallström CMims Magazine Vol 19 No 21 55 (1992)
Prophylactic therapy in depression Mims Magazine (1992) Guidelines for the management of patients with generalised anxiety (Consensus Panel) Psychiatric Bulletin, 1992 16, 560-565 Guidelines for the management of patients withdrawing from benzodiazepines Mental Health Foundation 1993 Guidelines for the treatment of depressive illness with antidepressants Montgomery S, Hallström, et al Journal of Psychopharmacology 1993 7: 19-23 Guidelines for the investigation of anti-anxiety drugs (Consensus Panel) British Association for Psychopharmacology (In press) Antidepressants in the treatment of anxiety disorder Tyrer P & Hallström C Psychiatric Bulletin 1993 Vol 17 75-76 ECT causes an increase in urinary output of the monoamine oxidase An inhibitory component of Tribulin Clow A, Kimber S, Sandler M, Hallström C, Hawley C, Glover V (Abstract) British Association of Psychopharmacology Meeting, 1993 Reading list for MRCGP examination on depression MIMS Magazine, October 5th 1993 Drugs in focus: Zopiclone. Prescriber Journal. 34. 115-119: 1994 Reshaping mental health services. (Review) The Psychiatric Bulletin. Waving a goodbye to mother's little helper
Focus on drug dependency, featuring Dr HallströmHospital Doctor 29 May 1993
Mental health care is worsening by the day (Letter to the Editor) Evening Standard 13 1 1995 Hallström C, Hirsch S What are the options for GPs when prescribing hypnotics? MIMS Weekly 4 10 94 Hallström C Rational choices in CNS prescribing: the cost of depression Prescriber 5:15 1994 24 - 29 Hypnotics MIMS Weekly 1995 Hallström C Costs of clozapine Bulletin of The Royal College of Psychiatrists 1995 Bottomley C, Hallström C The rating of depression Perspectives in Depression 4: 3 1996 1-5 Hallström C More ECT needed not less (Opinion) Care of the Elderly 7 No 3 1995 Hallström C Can GPs manage without benzodiazepines Prescriber Tranquillisers are good for you? Proceedings of The Medical Society of London Managing minor psychiatric conditions in adolescents Prescriber 19 January 1997 Hill-Smith A, Hallström C Medico-legal Aspects of Occupational Stress Journal of the Medico-legal Society 1997 Hallström C Hyperkinetic Disorder Progress in Neurology and Psychiatry Nov/Dec 1997 Hill-Smith A & Hallström C Mania, Schizophrenia and the Mental Health Act Update Pocket Guide to Insomnia 1997 Advisory Panel The Drug Management of Schizophrenia The Practitioner 1998 The Pharmacotherapy of Schizophrenia The Practitioner January 1998 Vol.242 Hallström C, Magnes R Stress and Mental Health Nursing Mental Health Care Hallström C, 1988 Benzodiazepine Dependence 20 Years On Progress in Neurology and Psychiatry Hallström C Differentiating anxiety from physical disorder in primary care Psychiatry Reviews, Vol 2, No 3 Autumn 1997 Hallström C, Galloway C Royal College of Psychiatrists Statement on Benzodiazepines 1997 (co-author) Stigma of Anxiety A Primary-care Guide to Insomnia Management Prescriber 5 April 2002 Hallström C
Contributors to Drugs and Therapeutic Bulletin
Tranquilliser independence (Self-help audio cassette for patients) Clinical Trials Amitriptyline vs butriptyline in depressed outpatients Phase 3 Clomipramine vs protriptyline in depressed outpatients, monitoring platelet uptake of 5-HT and dopamine. Clinical pharmacological study. Diazepam, propranolol and their combination for the treatment of chronic anxiety Clinical pharmacological study A clinical pharmacological study of benzodiazepine withdrawal Desenkephalin gamma endorphin and thioridazine in the treatment of schizophrenia; a placebo controlled study Phase 2 GRB 11909: A dose response relationship of selective dopamine uptake inhibitor in major depression Phase 2 BRG 21909: A double blind placebo controlled study versus Imipramine for the treatment of major depression. A multicentre multinational study Phase 3 Lofepramine vs desipramine in depressed outpatients Propranolol vs placebo in benzodiazepine withdrawal Clopixol concentrate vs Haldol decanoate in the maintenance treatment of schizophrenia Principal investigator Phase 4 Remoxipride in the longterm treatment of schizophrenia A multicentre study Investigator Long-term safety study Zacopride: a dose finding study of 5HT3 agonist in anxiety Multicentre study Investigator Phase 2
Investigator in A study of a DA antagonist antidepressant in depressed outpatients Phase 2
Investigator in A multicentre study of Prothiaden vs placebo in the treatment of benzodiazepine withdrawal Phase 4 UKMAS study of calcium homotaurinate in the prevention of relapse in alcoholism Investigator Phase 4 Buspirone: assessment in a general practice setting; A study of 670 patients in general practice Principal investigator Phase 4. Buspirone ER vs Buspirone IR. A multicentre, multinational study in primary care. Principal investigator. Phase 4. Flesinoxan vs placebo in anxiety A multicentre, multinational study in primary care; Trainer; Phase 3 Nefazodone vs fluoxetine in depressed patients in primary care A multinational study; Principal investigator; Phase 3 Nefazodone vs sertraline in depressed hospital outpatients Investigator; Phase 3 Ondansetron in the prevention of relapse in chronic anxiety Long-term relapse prevention of fluvoxamine in depression Investigator
Trainer in a study of amisulpiride in schizophrenia Sertraline vs imipramine in panic disorder
Trainer in a study of an antidepressant A multidimensional study
CLZ-20 499 - 006 -GBR A study of an anxiolytic in generalised anxiety disorder Relapse prevention in depression of ORG 4428 in outpatients Paroxetine -v- Placebo in Social Phobia Investigator in a Study of Antidepressants. ASTRA phase 2. Paroxetine -v- Placebo in GAD. Phase 3. Several other studies since – as coordinator/principal investigator Consultancies
To several pharmaceutical companies in relation to
marketing, product development and clinical research developmentMajor commitments include ICR Ltd, Glaxo and BristolMyers Squibb
Family, country weekends, skiing, travel, wine
Referees:
Dr. Anne CremonaConsultant PsychiatristCapio NightingaleEdward House7 Lisson GroveLondon NW1 6SH
Dr. William ShanahanExecutive Medical DirectorCapio Nightingale11-19 Lisson GroveLondon NW1 6SH
BASIC FIRE SAFETY Self-Study Guide OBJECTIVES OF THE BASIC FIRE SAFETY PROGRAM Upon completion of this self-study guide, you should be able to identify classes of fires, types of fire extinguishers and your role in the Basic Fire Safety Program. Successful completion of this program can be accomplished by completing the examination on the last page of this self-study guide with a s
PROGRAMA DE ACTOS E INFORMACIÓN DEL CLUB Con motivo de la celebración de la tradicional travesía a remo Santa Pola Tabarca Santa Pola, el Club Náutico de Santa Pola informa de los actos previstos, así como la información necesaria a los clubes para el buen funcionamiento del evento. El Club Náutico de Santa Pola, pondrá a disposición de los clubes participantes, todo aque